HL257

N/A

Report date: 2024/11/05 14:28:32

Base Information

Drug NameHL257
Drug Alias NameHL257HL-257
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAlpha-enolase inhibitors
TargetsAlpha-enolase
Therapy Area/IndicationsVascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHuniLife Biotechnology Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsVascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A